` Comparison: ONCO, AMGN - Alpha Spread

ONCO
vs
AMGN

Over the past 12 months, ONCO has significantly outperformed AMGN, delivering a return of +164% compared to the AMGN's 10% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ONCO
AMGN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

ONCO Intrinsic Value
2.73 SEK
Overvaluation 56%
Intrinsic Value
Price
AMGN Intrinsic Value
269.79 USD
Overvaluation 9%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Oncopeptides AB
STO:ONCO
6.15 SEK
Amgen Inc
NASDAQ:AMGN
296.06 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ONCO, AMGN

ONCO
AMGN
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Oncopeptides AB
Revenue
Amgen Inc
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
ONCO, AMGN

ONCO
AMGN
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Oncopeptides AB
STO:ONCO
Amgen Inc
NASDAQ:AMGN
What is Free Cash Flow?

Gross Margin

ONCO
94.3%
AMGN
64.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Oncopeptides AB
Amgen Inc

Operating Margin

ONCO
-696.9%
AMGN
25.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Oncopeptides AB
Amgen Inc

Net Margin

ONCO
-696.7%
AMGN
17.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Oncopeptides AB
Amgen Inc

FCF Margin

ONCO
-656.4%
AMGN
32%
LTM 3Y Avg 5Y Avg 10Y Avg
Oncopeptides AB
Amgen Inc

ROE

ONCO
3 890%
AMGN
105.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Oncopeptides AB
Amgen Inc

ROA

ONCO
-148.8%
AMGN
6.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Oncopeptides AB
Amgen Inc

ROIC

ONCO
-416.9%
AMGN
9.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Oncopeptides AB
Amgen Inc

ROCE

ONCO
-215.1%
AMGN
12.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Oncopeptides AB
Amgen Inc

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
ONCO, AMGN

Loading

Performance Gap
ONCO, AMGN

Loading
ONCO
AMGN
Difference
www.alphaspread.com

Performance By Year
ONCO, AMGN

Loading
ONCO
AMGN
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ONCO to other stocks
Unlock Full Access to Alpha Spread
Create Free Account